Camson Bio Technologies Ltd Half Yearly Results

Gross Sales

109.68

93.33

93.7

97.19

92.15

Excise Duty

0

0

0

0

0

Net Sales

109.68

93.33

93.7

97.19

92.15

Other Operating Income

0

0

0

0

0

Other Income

6.26

0.17

0.08

0.43

0.25

Total Income

115.94

93.51

93.78

97.62

92.4

Total Expenditure

106.84

81.41

79.71

90.02

73.88

PBIDT

9.1

12.07

14.07

7.61

18.51

Interest

3.1

1.99

2.12

1.75

1.22

PBDT

6

10.09

11.95

5.84

17.29

Depreciation

7.3

6.69

2.62

2.49

1.66

Minority Interest Before NP

0

0

0

0

0

Tax

2.77

-0.79

-1.14

0.66

0.47

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-4.07

4.17

10.47

2.7

15.14

Minority Interest After NP

-1.76

-0.05

-0.01

0

0.27

Net Profit after Minority Interest

-2.3

4.23

10.48

2.7

14.88

Extra-ordinary Items

0

0

0

-2.85

0

Adjusted Profit After Extra-ordinary item

-2.3

4.23

10.48

5.55

14.88

EPS (Unit Curr.)

0

1.4

4.16

1.1

8.21

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

30

30

25.23

25.22

18.12

Public Shareholding (Number)

2,26,61,240

2,26,61,240

1,85,86,913

1,74,86,912

1,21,93,616

Public Shareholding (%)

75.54

75.54

73.68

78.33

67.26

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

73,38,600

73,38,600

66,38,600

48,38,600

59,36,384

Non Encumbered - % in Total Promoters Holding

100

100

100

100

100

Non Encumbered - % in Total Equity

24.46

24.45

26.32

21.67

32.74

PBIDTM(%)

8.29

12.94

15.01

7.82

20.08

PBDTM(%)

-

-

-

-

-

PATM(%)

-3.71

4.47

11.17

2.77

16.44